Intermittent fasting for improving psoriasis and psoriatic arthritis
Role of Intermittent Fasting on Disease Severity and Quality of Life in Psoriasis and Psoriatic Arthritis
This study tests if intermittent fasting can help improve symptoms for people with psoriasis and psoriatic arthritis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ohio State University Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Trial ID | NCT05590247 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of intermittent fasting on the severity of psoriasis and psoriatic arthritis in patients at Ohio State University. Participants will be randomly assigned to either an intermittent fasting group or a standard diet group for 24 weeks. The study will assess changes in disease severity and quality of life through clinical evaluations and patient-reported outcomes. Follow-up assessments will occur every four weeks, with a focus on the feasibility of a larger study based on the results.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with mild to moderate plaque psoriasis who are overweight and have not changed their systemic treatment for at least six weeks.
Not a fit: Patients who are pregnant, breastfeeding, insulin-dependent diabetics, or have severe comorbid conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a novel dietary intervention to improve symptoms and quality of life for patients with psoriasis and psoriatic arthritis.
How similar studies have performed: While intermittent fasting has been explored in various contexts, this specific application for psoriasis and psoriatic arthritis is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age and older * Established patient at the clinical site with a diagnosis of mild to moderate plaque psoriasis despite treatment * Ability to consent and follow dietary instructions * Overweight (BMI ≥ 25) * No change in systemic psoriasis treatment for 6 weeks Exclusion Criteria: * Pregnancy and/or breastfeeding * Insulin-dependent diabetics * Severe heart, kidney, and liver disease * Obesity due to medical condition * Use of medical treatment for weight reduction
Where this trial is running
Columbus, Ohio
- The Ohio State University Wexner Medical Center — Columbus, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: Benjamin H Kaffenberger, MD, MS — Ohio State University
- Study coordinator: Ashley N Gray, BS
- Email: ashley.gray@osumc.edu
- Phone: 6142931707
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.